Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00887536
What this trial is testing

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,613
Not applicableLooking for participantsNCT05977036
What this trial is testing

BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer

Who this might be right for
Metastatic Breast CancerUnresectable Breast Cancer
Washington University School of Medicine 65
Not applicableStudy completedNCT05214144
What this trial is testing

The In4M Study: Integrating 4 Methods to Assess Physical Function in Cancer Patients

Who this might be right for
Physical FunctionCancer, BreastLymphoma+3 more
Yale University 208
Early research (Phase 1)Study completedNCT03343054
What this trial is testing

Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors

Who this might be right for
NeoplasmsBreast Neoplasms
Pfizer 28
Not applicableLooking for participantsNCT06672302
What this trial is testing

A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer

Who this might be right for
Breast Neoplasm
EXoPERT 330
Not applicableStudy completedNCT00003329
What this trial is testing

Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+1 more
Eastern Cooperative Oncology Group 4,000
Testing effectiveness (Phase 2)Study completedNCT00004172
What this trial is testing

Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Northwestern University
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06958445
What this trial is testing

Prevention of Oral Mucositis and Improvement of Quality of Life for Patients With Breast Cancer Undergoing Adjuvant Radiotherapy

Who this might be right for
Breast Carcinoma
Taipei City Hospital 90
Not applicableLooking for participantsNCT01788839
What this trial is testing

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

Who this might be right for
Breast CancerLymphomaHodgkin's Lymphoma
Memorial Sloan Kettering Cancer Center 475
Not applicableStudy completedNCT03769428
What this trial is testing

Postoperative Analgesia in Breast Cancer Surgery: Safety and Efficiency of Ultrasound Guided Erector Spinae Plane Block

Who this might be right for
Breast Cancer SurgeryPostoperative Analgesia
Ben marzouk Sofiene 60
Testing effectiveness (Phase 2)Ended earlyNCT01861054
What this trial is testing

Pilot Study to Evaluate Safety & Biological Effects of Orally Administered Reparixin in Early Breast Cancer

Who this might be right for
Breast Cancer
Dompé Farmaceutici S.p.A 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT06777537
What this trial is testing

Neoadjuvant Chemotherapy with or Without Talniflumate for the Treatment of Breast Cancer

Who this might be right for
Breast Cancer
Shandong University 200
Not applicableUnknownNCT06577545
What this trial is testing

Lifestyle Behavioural Intervention on Breast Cancer Survivors for the Treatment of Overweight/Obesity.

Who this might be right for
Breast Cancer FemaleOverweight and Obesity
University of Thessaly 92
Post-approval studies (Phase 4)UnknownNCT01049295
What this trial is testing

Omega-3 Fatty Acids and Chemotherapy-induced Neuropathy and Inflammation in Breast Cancer

Who this might be right for
Breast Cancer
Tehran University of Medical Sciences 52
Not applicableStudy completedNCT02329639
What this trial is testing

Prospective Study of VEGFR-2 /IL-8 Genetic Interaction in MBC Treated With Paclitaxel and Bevacizumab vs. Chemotherapy

Who this might be right for
Metastatic Breast Cancer
University of Pisa 307
Testing effectiveness (Phase 2)UnknownNCT06152822
What this trial is testing

Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases

Who this might be right for
Breast Cancer With Brain Metastases
Tongji Hospital 30
Very early researchStudy completedNCT01916122
What this trial is testing

Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 54
Not applicableStudy completedNCT00872677
What this trial is testing

Weight Loss Counseling for African American Women Who Are Breast Cancer Survivors

Who this might be right for
Breast CancerObesityWeight Changes
Barbara Ann Karmanos Cancer Institute 31
Very early researchUnknownNCT05886075
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors

Who this might be right for
Lung CancerBronchial CancerNon Small Cell Lung Cancer+9 more
Shanghai Yunying Medical Technology 24
Testing effectiveness (Phase 2)Ended earlyNCT00210028
What this trial is testing

Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Institut Claudius Regaud 40
Next Page